The ABCs of JAKis: A Clinician's Guide to Safety and Monitoring of the Systemic JAK Inhibitors

J Drugs Dermatol. 2024 Oct 1;23(10):856. doi: 10.36849/JDD.2024.8073.

Abstract

Janus kinase inhibitors (JAKis) have recently emerged in the arsenal of tools to treat dermatological conditions. However, there are some concerns regarding these treatments due to their boxed warning. Here we discuss the safe and effective use of JAKs for the treatment of a wide variety of dermatologic conditions. We will also discuss monitoring guidelines. J Drugs Dermatol. 2024;23(10):852-856. doi:10.36849/JDD.8073.

Publication types

  • Review

MeSH terms

  • Drug Monitoring* / methods
  • Humans
  • Janus Kinase Inhibitors* / administration & dosage
  • Janus Kinase Inhibitors* / adverse effects
  • Janus Kinase Inhibitors* / therapeutic use
  • Practice Guidelines as Topic
  • Skin Diseases* / drug therapy

Substances

  • Janus Kinase Inhibitors